Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma

被引:410
作者
Halazun, Karim J. [1 ]
Hardy, Mark A. [1 ]
Rana, Abbas A. [1 ]
Woodland, David C., III [1 ]
Luyten, Elijah J. [1 ]
Mahadev, Suhari [1 ]
Witkowski, Piotr [1 ]
Siegel, Abbey B. [1 ]
Brown, Robert S., Jr. [1 ]
Emond, Jean C. [1 ]
机构
[1] Columbia Univ, New York Presbyterian Hosp, Dept Organ Transplantat, New York, NY 10032 USA
关键词
ENDOTHELIAL GROWTH-FACTOR; C-REACTIVE PROTEIN; CYCLOOXYGENASE-2 INHIBITOR ROFECOXIB; NEEDLE TRACT IMPLANTATION; COLORECTAL-CANCER; CURATIVE RESECTION; HEPATIC RESECTION; PREOPERATIVE NEUTROPHIL; CIRRHOTIC-PATIENTS; TUMOR RECURRENCE;
D O I
10.1097/SLA.0b013e3181a77e59
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The Milan criteria have been adopted by United Network for Organ Sharing (UNOS) to preoperatively assess outcome in patients will hepatocellular carcinoma (HCC) who receive orthotopic liver transplantation (OLT). These criteria rely solely on radiographic appearances of the tumor, providing no measure of tumor biology. Recurrence rates, therefore, remain around 20% for patients within the criteria. The neutrophil-lymphocyte ratio (NLR) is an indicator of inflammatory Status previously established as a prognostic indicator in colorectal liver metastases. We aimed to determine whether NLR predicts outcome in patients undergoing OLT for HCC. Design: Analysis of patients undergoing OLT for HCC between 2001 and 2007 at our institution. A NLR >= 5 was considered to be elevated. Results: A total of 150 patients were identified, with 13 patients having all elevated NLR. Of these, 62% developed recurrence compared with 14% with normal NLR (P < 0.0001). The disease-free survival for patients with high NLR was significantly worse than that for patients with normal NLR (1-, 3-, and 5-year survivals of 38%, 25%, and 25% vs. 92%, 85%, and 75%, P < 0.0001). Patients with high NLR also had poorer overall survival (5-year survival, 28% vs. 64%, P = 0.001). Patients within Milan with all elevated NLR had significantly poorer disease-free survival than those with normal NLR within Milan (5-year survival, 30% vs. 81%, P < 0.0001). On univariate analysis, 9 factors including all NLR >= 5 were significant predictors of poor disease-free survival. However, only a raised NLR remained significant on multivariate analysis (P = 0.005, HR: 19.98). Conclusion: Elevated NLR significantly increases the risk for tumor recurrence and recipient death. Preoperative NLR measurement may provide a simple method of identifying patients with poorer prognosis and act as an adjunct to Milan in determining, which patients benefit most from OLT.
引用
收藏
页码:141 / 151
页数:11
相关论文
共 58 条
  • [1] Adachi E, 1996, CANCER, V77, P2022, DOI 10.1002/(SICI)1097-0142(19960515)77:10<2022::AID-CNCR9>3.0.CO
  • [2] 2-S
  • [3] Selective COX-2 inhibitor, NS-398, suppresses cellular proliferation in human hepatocellular carcinoma cell lines via cell cycle arrest
    Baek, Ji Yeon
    Hur, Wonhee
    Wang, Jin Sang
    Bae, Si Hyun
    Ybon, Seung Kew
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (08) : 1175 - 1181
  • [4] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [5] Brodsky SV, 2007, J GASTROINTEST LIVER, V16, P373
  • [6] Identification of metastasis-related microRNAs in hepatocellular carcinoma
    Budhu, Anuradha
    Jia, Hu-Liang
    Forgues, Marshonna
    Liu, Chang-Gong
    Goldsteir, David
    Lam, Amy
    Zanetti, Krista A.
    Ye, Qing-Hai
    Qin, Lun-Yju
    Croce, Carlo M.
    Tang, Zhao-You
    Wang, Xin Wei
    [J]. HEPATOLOGY, 2008, 47 (03) : 897 - 907
  • [7] Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases
    Chalmers, C. R.
    Wilson, D. J.
    Ward, J.
    Robinson, P. J.
    Toogood, G. J.
    Hull, M. A.
    [J]. GUT, 2006, 55 (07) : 1058 - 1059
  • [8] Needle tract implantation after sonographically guided percutaneous biopsy of hepatocellular carcinoma: Evaluation of doubling time, frequency, and features on CT
    Chang, S
    Kim, SH
    Lim, HK
    Lee, WJ
    Choi, SL
    Lim, JH
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2005, 185 (02) : 400 - 405
  • [9] Prognostic significance of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin in patients with resectable hepatocellular carcinoma after surgery
    Chao, Y
    Li, CP
    Chau, GY
    Chen, CP
    King, KL
    Lui, WY
    Yen, SH
    Chang, FY
    Chan, WK
    Lee, SD
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (04) : 355 - 362
  • [10] Inflammation and cancer
    Coussens, LM
    Werb, Z
    [J]. NATURE, 2002, 420 (6917) : 860 - 867